Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor

Eur J Haematol. 2006 Mar;76(3):258-60. doi: 10.1111/j.1600-0609.2005.00594.x.

Abstract

Secondary or late graft failure has been defined as the development of inadequate marrow function after initial engraftment has been achieved. We describe a case of profound marrow aplasia occurring 13 years after sibling allogeneic bone marrow transplantation for chronic myeloid leukaemia (CML) in first chronic phase. Although the patient remained a complete donor chimera, thereby suggesting that an unselected infusion of donor peripheral blood stem cells (PBSC) or bone marrow might be indicated, the newly acquired aplasia was thought to be immune in aetiology and some immunosuppression was therefore considered appropriate. Rapid haematological recovery was achieved after the infusion of unselected PBSC from the original donor following conditioning with anti-thymocyte globulin (ATG).

Publication types

  • Case Reports

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Bone Marrow Diseases / drug therapy
  • Bone Marrow Diseases / etiology*
  • Bone Marrow Diseases / pathology
  • Bone Marrow Transplantation / adverse effects*
  • Bone Marrow Transplantation / methods
  • Female
  • Histocompatibility Testing
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Siblings
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Antilymphocyte Serum